Culture, Yeast
Most systemic yeast infections are seen in immunocompromised patients including those with inherited immunodeficiencies, AIDS and transplant patients. In addition, yeast infection can also occur in patients after surgery and patient who are receiving on long-term intravenous therapy without adequate catheter care. Yeast infection can be more commonly seen as local infections such as those of the skin, vaginal and nails.
Candida spp. are the most common yeast pathogens and infections may be caused by variety of species. Candida albicans is the most frequent etiologic agent, followed by Candid tropicalis, Candida parapsilosis and Candida glabrata. A number of other species have been involved in infections in immunocompromised patients; however, their prevalence is low. Candida spp. are part of the normal microbiota in the human gastrointestinal and genitourinary tracts. As opportunistic pathogens they are responsible for several different types of infections in healthy and immunocompromised patients. The most common infections are skin candidiasis, such as paronychia; onychomycosis, vulvovaginitis, thrush, but they may also cause pulmonary infection, ocular infection, endocarditis, meningitis, fungemia, and disseminated infections or sepsis. The severe infections are most common in immunocompromised patients, whereas local infection may occur in healthy hosts.
Most Candida spp. grow well on non-selective agar media used for bacterial culture. Candida ChromAgar is a selective and differential medium containing chromogenic substrates that facilitates the detection of mixed yeast cultures. After degradation by specific enzymes the substrates release different colored compounds and thus allows for the differentiation of C. albicans, C. tropicalis, C glabrata and C. krusei based on differences in colony morphology and color. Colonies of C. albicans appear green to dark metallic green, C. tropicalis colonies appear medium blue to dark metallic blue with a blue halo, and C. krusei colonies appear flat, often rough or crenated, and pink to medium pink in color. Candida glabrata colonies appear pale pink to mauve pink with a moist consistency. Other species appear white, cream or very pale pink.
- Diagnosis of yeast infections from various sources and body sites
- Monitor for efficacy after anti-fungal/yeast therapy
- Manage chronic recurring yeast disease
- Determines correct anti-fungal/yeast therapy
Negative:
- No growth on the media either indicates that no infection is present, or that the pathogen was not successfully cultured.
Positive:
- The growth of a potentially pathogenic organism may indicate an infection that requires treatment, but the clinician must determine whether or not the presence of an organism is significant.
No growth (Negative) or only the growth of normal flora
Specimen Type
Variety of sites; hair, nails, skin, respiratory, conjunctiva, vaginal, aspirates of body fluids and others should be collected in sterile container or swab with transport media and blood culture bottles for blood collection.
Biopsy
Surgical specimen in sterile container. Sterile nonbacteriostatic water may be used to prevent drying. Body fluid, aspirates: Aspirated material in sterile container.
Skin and nails
Cleanse the area with 70% alcohol prior to specimen collection. Nail scraping should be from a subsurface portion of the infected nail. Skin should be taken from the active border of the lesion.
Stool
Random sample in sterile container.
Swabs of throat, nose, nasopharynx, ear
Swab affected area or visible lesion. Transfer swab in non-nutritional media if possible.
Urine
Clean catch midstream sample in sterile container.
Wound
Aspirate of purulent material or fluid; scraping of lesion border, or swab (least preferred) in sterile container.
Stability of specimen vary based on source, collection device and container.
- Bailey & Scott's Diagnostic Microbiology Mosby; 14 edition (December 21, 2016). Chapter 53 page 779-787.
- Mandell GL, Bennett J (eds). Mandell and Bennett's Principles and Practices of Infectious Diseases, 4th Edition. New York:
- Churchill Livingstone (1995).
- Forbes BA, Sahm DF, Weissfeld AS (eds). Bailey and Scott’s Diagnostic Microbiology, 11th ed. (2002). p.927-938.
- Culture, Fungus. In Mayo Medical Laboratories Interpretive Guide (pp. 239-241). Boston (2007-2008).
- Kavanaugh K. Medical Mycology: Cellular And Molecular Techniques. New York: John Wiley & Sons (2006).